3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Pain, Procedural
1
Disease
1
CIPN - Chemotherapy-Induced Peripheral Neuropathy
1
Anatomic Stage I Breast Cancer AJCC v8
1
Agnosia
1
Interventions
Magnetic Resonance Spectroscopy
55
enzalutamide
47
apalutamide
37
Specimen Handling
36
Androgen Antagonists
35
Abiraterone Acetate
32
Prednisone
29
darolutamide
28
Radiosurgery
27
Docetaxel
23
abiraterone
22
Pluvicto
22
Radiotherapy
21
Leuprolide
19
Biopsy
16
relugolix
14
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
14
Surveys and Questionnaires
13
gallium 68 PSMA-11
12
Triptorelin Pamoate
12
Radiation
12
Gonadotropin-Releasing Hormone
12
Nivolumab
11
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
11
cabazitaxel
10
bicalutamide
10
X-Rays
10
Standard of Care
10
Goserelin
9
Carboplatin
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Transcutaneous Electric Nerve Stimulation
×
90 days
×
Clear all
NCT07578324
2026-05-11
TENS 2
Medical University of Gdansk
Phase NA
Not yet recruiting
140 enrolled